MeCP2 post-translational modifications: A mechanism to control its involvement in synaptic plasticity and homeostasis?

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Bellini, Elisa ^a   Pavesi, Giulio ^b   Barbiero, Isabella ^c   Bergo, Anna ^c   Chandola, Chetan ^c   Nawaz, Mohammad S ^c   Rusconi, Laura ^c   Stefanelli, Gilda ^c   Strollo, Marta ^c   Valente, Maria M ^a   Kilstrup Nielsen, Charlotte ^c   Landsberger, Nicoletta ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Chromatin; MeCP2; Mouse models; Phosphorylation; Post translational modifications; Rett syndrome; Synaptic plasticity

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE H1; METHYL CPG BINDING PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RNA BINDING PROTEIN; SUMO 1 PROTEIN;

CHROMATIN STRUCTURE; DNA METHYLATION; EXCITATION AND STIMULATION; GENE OVEREXPRESSION; GENOTYPE PHENOTYPE CORRELATION; HIPPOCAMPAL NEURONAL CULTURE; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MISSENSE MUTATION; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; RETT SYNDROME; REVIEW; RNA SPLICING; SYNAPTIC TRANSMISSION; TRANSCRIPTION REGULATION; UBIQUITINATION;

EID: 84922367562     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00236     Document Type: Review

References (111)

1. Adams, V. H., McBryant, S. J., Wade, P. A., Woodcock, C. L., and Hansen, J. C. (2007). Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem. 282, 15057-15064. doi: 10.1074/jbc.M700855200
2. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188. doi: 10.1038/13810
3. Ausió, J., Paz, A. M., and Esteller, M. (2014). MeCP2: the long trip from a chromatin protein to neurological disorders. Trends Mol. Med. doi: 10.1016/j.molmed.2014.03.004. [Epub ahead of print].
4. Bauman, M. L., Kemper, T. L., and Arin, D. M. (1995). Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 45, 1581-1586. doi: 10.1212/WNL.45.8.1581
5. Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villén, J., Li, J., et al. (2004). Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. U.S.A. 101, 12130-12135. doi: 10.1073/pnas.0404720101
6. Bedogni, F., Riccardo, R., Galli, F., Cobolli Gigli, C., Gandaglia, A., Kilstrup-Nielsen, C., et al. (2014). Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2014.01.011. [Epub ahead of print].
7. Belichenko, N. P., Belichenko, P. V., and Mobley, W. C. (2009b). Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol. Dis. 34, 71-77. doi: 10.1016/j.nbd.2008.12.016
8. Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., et al. (2009a). Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 514, 240-258. doi: 10.1002/cne.22009
9. Bennetzen, M. V., Larsen, D. H., Bunkenborg, J., Bartek, J., Lukas, J., and Andersen, J. S. (2010). Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell. Proteomics 9, 1314-1323. doi: 10.1074/mcp.M900616-MCP200
10. Blom, N., Gammeltoft, S., and Brunak, S. (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351-1362. doi: 10.1006/jmbi.1999.3310
11. Bracaglia, G., Conca, B., Bergo, A., Rusconi, L., Zhou, Z., and Greenberg, M. E. (2009). Methyl-CpG binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis. EMBO Rep. 10, 1327-1333. doi: 10.1038/embor.2009.217
12. Carrascal, M., Ovelleiro, D., Casas, V., Gay, M., and Abian, J. (2008). Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J. Proteome Res. 7, 5167-5176. doi: 10.1021/pr800500r
13. Chahrour, M., and Zoghbi, H. Y. (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437. doi: 10.1016/j.neuron.2007.10.001
14. Chandler, S. P., Guschin, D., Landsberger, N., and Wolffe, A. P. (1999). The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38, 7008-7018. doi: 10.1021/bi990224y
15. Chapleau, C. A., Boggio, E. M., Calfa, G., Percy, A. K., Giustetto, M., and Pozzo-Miller, L. (2012). Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage. Neural Plast. 976164. doi: 10.1155/2012/976164
16. Chapleau, C. A., Calfa, G. D., Lane, M. C., Albertson, A. J., Larimore, J. L., Kudo, S., et al. (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol. Dis. 35, 219-233. doi: 10.1016/j.nbd.2009.05.001
17. Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T., Qin, J., et al. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229. doi: 10.1126/science.1153252
18. Chen, R. Q., Yang, Q. K., Lu, B. W., Yi, W., Cantin, G., Chen, Y. L., et al. (2009). CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 69, 2663-2668. doi: 10.1158/0008-5472.CAN-08-3222
19. Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A., Griffith, E. C., et al. (2003). Depression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889. doi: 10.1126/science.1086446
20. Cheng, J., Huang, M., Zhu, Y., Xin, Y. J., Zhao, Y. K., Huang, J., et al. (2014). SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. J. Nurochem. 128, 798-806. doi: 10.1111/jnc.12523
21. Chernorudskiy, A. L., and Gainullin, M. R. (2013). Ubiquitin system: direct effects join the signaling. Sci. Signal. 6:pe22. doi: 10.1126/scisignal.2004251
22. Cheval, H., Guy, J., Merusi, C., De Sousa, D., Selfridge, J., and Bird, A. (2012). Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet. 21, 3806-3814. doi: 10.1093/hmg/dds208
23. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., et al. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840. doi: 10.1126/science.1175371
24. Christensen, G. L., Kelstrup, C. D., Lyngsø, C., Sarwar, U., Bøgebo, R., Sheikh, S. P., et al. (2010). Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol. Cell. Proteomics 9, 1540-1553. doi: 10.1074/mcp.M900550-MCP200
25. Ciccarelli, A., Calza, A., Santoru, F., Grasso, F., Concas, A., Sassoè-Pognetto, M., et al. (2013). Morphine withdrawal produces ERK-dependent and ERK-independent epigenetic marks in neurons of the nucleus accumbens and lateral septum. J. Neuropharm. 70, 168-179. doi: 10.1016/j.neuropharm.2012.12.010
26. Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., et al. (2011). Genome-wide activitydependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85. doi: 10.1016/j.neuron.2011.08.022
27. Courcelles, M., Frémin, C., Voisin, L., Lemieux, S., Meloche, S., and Thibault, P. (2013). Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol. Syst. Biol. 9:669. doi: 10.1038/msb.2013.25
28. De Filippis, B., Ricceri, L., and Laviola, G. (2010). Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome. Genes Brain Behav. 9, 213-223. doi: 10.1111/j.1601-183X.2009.00551.x
29. Demirkan, G., Yu, K., Boylan, J. M., Salomon, A. R., and Gruppuso, P. A. (2011). Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1). PLoS ONE 6:e21729. doi: 10.1371/journal.pone.0021729
30. Deng, J. V., Rodriguiz, R. M., Hutchinson, A. N., Kim, L. H., Wetsel, W. C., and West, A. E. (2010). MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat. Neurosci. 13, 1128-1136. doi: 10.1038/nn.2614
31. Deng, J. V., Wan, Y., Wang, X., Cohen, S., Wetsel, W. C., Greenberg, M. E., et al. (2014). MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity. J. Neurosci. 34, 4519-4527. doi: 10.1523/JNEUROSCI.2821-13.2014
32. Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Elledge, S. J., and Gygi, S. P. (2008). A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767. doi: 10.1073/pnas.0805139105
33. Ebert, D. H., Gabel, H. W., Robinson, N. D., Kastan, N. R., Hu, L. S., Cohen, S., et al. (2013). Activity-dependent phosphorylation of MECP2 threonine 308 regulates interaction with NcoR. Nature 499, 341-345. doi: 10.1038/nature12348
34. Garg, S. K., Lioy, D. T., Cheval, H., McGann, J. C., Bissonnette, J. M., Murtha, M. J., et al. (2013). Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J. Neurosci. 33, 13612-13620. doi: 10.1523/JNEUROSCI.1854-13.2013
35. Georgel, P. T., Horowitz-Scherer, R. A., Adkins, N., Woodcock, C. L., Wade, P. A., and Hansen, J. C. (2003). Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181-32188. doi: 10.1074/jbc.M305308200
36. Giacometti, E., Luikenhuis, S., Beard, C., and Jaenisch, R. (2007). Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl. Acad. Sci. U.S.A. 104, 1931-1936. doi: 10.1073/pnas.0610593104
37. Gonzales, M. L., Adams, S., Dunaway, K. W., and LaSalle, J. M. (2012). Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol. Cell. Biol. 32, 2894-2903. doi: 10.1128/MCB.06728-11
38. Goswami, T., Li, X., Smith, A. M., Luderowski, E. M., Vincent, J. J., Rush, J., et al. (2012). Comparative phosphoproteomic analysis of neonatal and adult murine brain. Proteomics 12, 2185-2189. doi: 10.1002/pmic.201200003
39. Grimsrud, P. A., Carson, J. J., Hebert, A. S., Hubler, S. L., Niemi, N. M., Pagliarini, D. J., et al. (2012). A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab. 16, 672-683. doi: 10.1016/j.cmet.2012.10.004
40. Guo, A., Gu, H., Zhou, J., Mulhern, D., Wang, Y., Lee, K. A., et al. (2014). Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell. Proteomics 13, 372-387. doi: 10.1074/mcp.O113.027870
41. Guy, J., Cheval, H., Selfridge, J., and Bird, A. (2011). The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631-652. doi: 10.1146/annurev-cellbio-092910-154121
42. Guy, J., Gan, J., Selfridge, J., Cobb, S., and Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147. doi: 10.1126/science.1138389
43. Herskowitz, J. H., Seyfried, N. T., Duong, D. M., Xia, Q., Rees, H. D., Gearing, M., et al. (2010). Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J. Proteome Res. 9, 6368-6379. doi: 10.1021/pr100666c
44. Ho, K. L., McNae, I. W., Schmiedeberg, L., Klose, R. J., Bird, A. P., and Walkinshaw, M. D. (2008). MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell 29, 525-531. doi: 10.1016/j.molcel.2007.12.028
45. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B., et al. (2012). PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270. doi: 10.1093/nar/gkr1122
46. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., et al. (2011). The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322. doi: 10.1126/science.1199498
47. Hutchinson, A. N., Deng, J.-V., Cohen, S., and West, A. E. (2012). Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action. J. Neurosci. 32, 321-337. doi: 10.1523/JNEUROSCI.2156-12.2012
48. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., et al. (2010). A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189. doi: 10.1016/j.cell.2010.12.001
49. Iliuk, A. B., Martin, V. A., Alicie, B. M., Geahlen, R. L., and Tao, W. A. (2010). In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol. Cell. Proteomics 9, 2162-2172. doi: 10.1074/mcp.M110.000091
50. Johnston, M. V., Blue, M. E., and Naidu, S. (2005). Rett syndrome and neuronal development. J. Child Neurol. 20, 759-763. doi: 10.1177/08830738050200082601
51. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., et al. (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19, 187-191. doi: 10.1038/561
52. Jugloff, D. G. M., Vandamme, K., Logan, R., Visanji, N. P., Brotchie, J. M., and Eubanks, J. H. (2008). Targeted delivery of an MeCP2 transgene to forebrain neurons improves the behavior of female MeCP2-deficient mice. Hum. Mol. Genet. 17, 1386-1396. doi: 10.1093/hmg/ddn026
53. Jung, S. Y., Li, Y., Wang, Y., Chen, Y., Zhao, Y., and Qin, J. (2008). Complications in the assignment of 14 and 28 Da mass shift detected by mass spectrometry as in vivo methylation from endogenous proteins. Anal. Chem. 80, 1721-1729. doi: 10.1021/ac7021025
54. Khoshnan, A., and Patterson, P. H. (2012). Elevated IKKα accelerates the differentiation of human neuronal progenitor cells and induces MeCP2-dependent BDNF expression. PLoS ONE 7:e41794. doi: 10.1371/journal.pone.0041794
55. Kishi, N., and Macklis, J. D. (2004). MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci. 27, 306-321. doi: 10.1016/j.mcn.2004.07.006
56. Klose, R. J., and Bird, A. P. (2004). MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J. Biol. Chem. 279, 46490-46496. doi: 10.1074/jbc.M408284200
57. Landi, S., Putignano, E., Boggio, E. M., Giustetto, M., Pizzorusso, T., and Ratto, G. M. (2011). The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome. Sci. Rep. 1, 45-51. doi: 10.1038/srep00045
58. Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., et al. (1992). Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914. doi: 10.1016/0092-8674(92)90610-O
59. Li, H., Zhong, X., Chau, K. F., Williams, E. C., and Chang, Q. (2011). Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat. Neurosci. 14, 1001-1008. doi: 10.1038/nn.2866
60. Li, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Lovén, J., et al. (2013). Global transcriptional and translational repression in human-emmbryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458. doi: 10.1016/j.stem.2013.09.001
61. Long, S. W., Ooi, J. Y., Yau, P. M., and Jones, P. L. (2011). A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci. Rep. 31, 333-343. doi: 10.1042/BSR20100124
62. Luikenhuis, S., Giacometti, E., Beard, C. F., and Jaenisch, R. (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 6033-6038. doi: 10.1073/pnas.0401626101
63. Lyst, M. J., Ekiert, R., Ebert, D. H., Merusi, C., Nowak, J., Selfridge, J., et al. (2013). Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci. 167, 898-902. doi: 10.1038/nn.3434
64. Mao, L. M., Horton, E., Guo, M. L., Xue, B., Jin, D. Z., Fibuch, E. E., et al. (2011). Cocaine increases phosphorylation of MeCP2 in the rat striatum in vivo: a differential role of NMDA receptors. Neurochem. Int. 56, 610-617. doi: 10.1016/j.neuint.2011.04.013
65. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., et al. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893. doi: 10.1126/science.1090842
66. Maunakea, A. K., Chepelev, I., Cui, K., and Zhao, K. (2013). Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 23, 1256-1269. doi: 10.1038/cr.2013.110
67. Mayya, V., Lundgren, D. H., Hwang, S. I., Rezaul, K., Wu, L., Eng, J. K., et al. (2009). Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. 2:ra46. doi: 10.1126/scisignal.2000007
68. McGraw, C. M., Samaco, R. C., and Zoghbi, H. Y. (2011). Adult neural function requires MeCP2. Science 333:186. doi: 10.1126/science.1206593
69. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430. doi: 10.1016/j.cell.2012.11.022
70. Moutri, A. R., Marchetto, M. C., Coufal, N. G., Oefner, R., Yeo, G., Nakashima, K., et al. (2010). L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446. doi: 10.1038/nature09544
71. Na, E. S., Nelson, E. D., Kavalali, E. T., and Monteggia, L. M. (2013). The impact of MeCP2 loss-or gain-of-function on synaptic plasticity. Neuropsychopharmacology 38, 212-219. doi: 10.1038/npp.2012.116
72. Nan, X., Campoy, F. J., and Bird, A. (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481. doi: 10.1016/S0092-8674(00)81887-5
73. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., et al. (1998). Transcriptional repression by the methyl-CpG binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-399. doi: 10.1038/30764
74. Neul, J., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944-950. doi: 10.1002/ana.22124
75. Neul, J. L., and Zoghbi, H. Y. (2004). Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist 10, 118-128. doi: 10.1177/1073858403260995
76. Nguyen, M. V., Du, F., Felice, C. A., Shan, X., Nigam, A., Mandel, G., et al. (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 32, 10021-10034. doi: 10.1523/JNEUROSCI.1316-12.2012
77. Nikitina, T., Shi, X., Ghosh, R. P., Howitz-Scherer, R. A., Hansen, J. C., and Woodcock, C. L. (2007). Multiple modes of interactions between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol. 27, 864-877. doi: 10.1128/MCB.01593-06
78. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., et al. (2010). Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3:ra3. doi: 10.1126/scisignal.2000475
79. Percy, A. K., and Lane, J. B. (2005). Rett syndrome: model of neurodevelopmental disorders. J. Child Neurol. 20, 718-721. doi: 10.1177/08830738050200090301
80. Phanstiel, D. H., Brumbaugh, J., Wenger, C. D., Tian, S., Probasco, M. D., Bailey, D. J., et al. (2011). Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 8, 821-827. doi: 10.1038/nmeth.1699
81. Picker, J. D., Yang, R., Ricceri, L., and Berger-Sweeney, J. (2006). An altered neonatal behavioral phenotype in Mecp2 mutant mice. Neuroreport 17, 541-544. doi: 10.1097/01.wnr.0000208995.38695.2f
82. Raijmakers, R., Kraiczek, K., de Jong, A. P., Mohammed, S., and Heck, A. J. (2010). Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer. Anal. Chem. 82, 824-832. doi: 10.1021/ac901764g
83. Rexach, J. E., Rogers, C. J., Yu, S. H., Tao, J., Sun, Y. E., and Hsieh-Wilson, L. C. (2010). Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 6, 645-651. doi: 10.1038/nchembio.412
84. Ricceri, L., De Filippis, B., and Laviola, G. (2008). Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav. Pharmacol. 19, 501-517. doi: 10.1097/FBP.0b013e32830c3645
85. Ricciardi, S., Boggio, E. M., Grosso, S., Lonetti, G., Forlani, G., Stefanelli, G., et al. (2011). Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum. Mol. Genet. 20, 1182-1196. doi: 10.1093/hmg/ddq563
86. Rigbolt, K. T., Prokhorova, T. A., Akimov, V., Henningsen, J., Johansen, P. T., Blagoev, B., et al. (2011). System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 4:rs3. doi: 10.1126/scisignal.2001570
87. Rinschen, M. M., Yu, M. J., Wang, G., Boia, E. S., Hoffert, J. D., Pisitkun, T., et al. (2010). Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc. Natl. Acad. Sci. U.S.A. 107, 3882-3887. doi: 10.1073/pnas.0910646107
88. Santos, M., Silva-Fernandes, A., Oliviera, P., Sousa, N., and Maciel, P. (2007). Evidence for abnormal early development in a mouse model of Rett syndrome. Genes Brain Behav. 6, 277-286. doi: 10.1111/j.1601-183X.2006.00258.x
89. Schüle, B., Armstrong, D. D., Vogel, H., Oviedo, A., and Francke, U. (2008). Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure. Clin. Genet. 74, 116-126. doi: 10.1111/j.1399-0004.2008.01005.x
90. Shahbazian, M. D., Antalffy, B., Armstrong, D. L., and Zoghbi, H. Y. (2002). Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115-124. doi: 10.1093/hmg/11.2.115
91. Shiromizu, T., Adachi, J., Watanabe, S., Murakami, T., Kuga, T., Muraoka, S., et al. (2013). Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric human proteome project. J. Proteome Res. 12, 2414-2421. doi: 10.1021/pr300825v
92. Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R., James, K. D., Turner, D. J., et al. (2010). Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468. doi: 10.1016/j.molcel.2010.01.030
93. Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N. E., Martinowich, K., et al. (2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc. Natl. Acad. Sci. U.S.A. 106, 4882-4887. doi: 10.1073/pnas.0811648106
94. Thambirajah, A. A., Eubanks, J. H., and Ausio', J. (2009). MeCP2 post-translational regulation through PEST domains: two novel hyptheses. Bioessays 31, 561-569. doi: 10.1002/bies.200800220
95. Trinidad, J. C., Barkan, D. T., Gulledge, B. F., Thalhammer, A., Sali, A., Schoepfer, R., et al. (2012). Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol. Cell. Proteomics 11, 215-229. doi: 10.1074/mcp.O112.018366
96. Tweedie-Cullen, R. Y., Reck, J. M., and Mansuy, I. M. (2009). Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J. Proteome Res. 8, 4966-4982. doi: 10.1021/pr9003739
97. Van Esch, H. (2011). MECP2 duplication syndrome. Mol. Syndromol. 2, 128-113.
98. Wagner, S. A., Beli, P., Weiner, B. T., Nielsen, M. L., Cox, J., Mann, M., et al. (2011). A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10, M111.013284.
99. Wang, Y. T., Tsai, C. F., Hong, T. C., Tsou, C. C., Lin, P. Y., Pan, S. H., et al. (2010). An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J. Proteome Res. 9, 5582-5597. doi: 10.1021/pr100394u
100. Weber, C., Schreiber, T. B., and Daub, H. (2012). Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J. Proteomics 75, 1343-1356. doi: 10.1016/j.jprot.2011.11.004
101. Wiśniewski, J. R., Nagaraj, N., Zougman, A., Gnad, F., and Mann, M. (2010). Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J. Proteome Res. 9, 3280-3289. doi: 10.1021/pr1002214
102. Wu, X., Tian, L., Li, J., Zhang, Y., Han, V., Li, Y., et al. (2012). Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol. Cell. Proteomics 11, 1640-1651. doi: 10.1074/mcp.M112.019091
103. Xue, Y., Ren, J., Gao, X., Jin, C., Wen, L., and Yao, X. (2008). GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7, 1598-1608. doi: 10.1074/mcp.M700574-MCP200
104. Yang, F., Stenoien, D. L., Strittmatter, E. F., Wang, J., Ding, L., Lipton, M. S., et al. (2006). Phosphoproteome profiling of human skin fibroblast cells in response to low-and high-dose irradiation. J. Proteome Res. 5, 1252-1260. doi: 10.1021/pr060028v
105. Young, J. I., Hong, E. P., Castle, J. C., Crespo-Barreto, J., Bowman, A. B., Rose, M. F., et al. (2006). Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. U.S.A. 102, 17551-17558. doi: 10.1073/pnas.0507856102
106. Yu, Y., Yoon, S. O., Poulogiannis, G., Yang, Q., Ma, X. M., Villén, J., et al. (2011). Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326. doi: 10.1126/science.1199484
107. Yusufzai, T. M., and Wolffe, A. P. (2000). Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28, 4172-4179. doi: 10.1093/nar/28.21.4172
108. Zanivan, S., Gnad, F., Wickström, S. A., Geiger, T., Macek, B., Cox, J., et al. (2008). Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J. Proteome Res. 7, 5314-5326. doi: 10.1021/pr800599n
109. Zhou, H., Di Palma, S., Preisinger, C., Peng, M., Polat, A. N., Heck, A. J., et al. (2013). Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. 12, 260-271. doi: 10.1021/pr300630k
110. Zhou, Z., Hong, E. J., Cohen, S., Zhao, W. N., Ho, H. Y. H., Schmidt, L., et al. (2006). Brain-specific phosphorylation of MeCP2 regulates activity dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255-269. doi: 10.1016/j.neuron.2006.09.037
111. Zocchi, L., and Sassone-Corsi, P. (2012). SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 7, 695-700. doi: 10.4161/epi.20733